Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Lacosamide fda approval date?

See the DrugPatentWatch profile for Lacosamide

Lacosamide (brand Vimpat) was approved by the FDA on March 26, 2008, as an adjunctive therapy for adults with partial-onset seizures. It later received additional indications and formulation approvals. If you’d like, I can share the official FDA press release or provide more details on later approvals.



Other Questions About Lacosamide :

Are there any reported side effects of lacosamide? Is lacosamide safe for hypertension patients? Lacosamide brand? Lacosamide alternatives? Are there alternative medications to lacosamide? Is lacosamide more effective than other options? Are frequent lacosamide dosage changes recommended?